DC Infotech and Communication Limited (NSE:DCI)

CTI BioPharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,065	3,252	2,400	1,205	504	286
Market Cap Growth	26.48%	35.51%	99.19%	139.05%	76.47%	22.05%
Enterprise Value	3,341	3,666	2,699	1,424	596	486
Last Close Price	235.80	250.15	184.60	100.40	42.00	23.80
PE Ratio	24.47	22.43	20.67	17.03	12.59	12.99
PS Ratio	0.52	0.59	0.52	0.34	0.22	0.16
PB Ratio	4.24	4.50	4.74	4.08	2.25	1.55
P/TBV Ratio	4.24	4.50	4.74	4.08	2.25	1.55
P/FCF Ratio	-	-	-	-	6.24	26.66
P/OCF Ratio	-	-	-	-	5.27	23.45
EV/Sales Ratio	0.57	0.66	0.59	0.40	0.26	0.28
EV/EBITDA Ratio	12.22	14.06	13.48	10.37	7.65	9.20
EV/EBIT Ratio	12.47	14.37	13.86	10.94	8.06	9.72
EV/FCF Ratio	-	-	-	-	7.37	45.32
Debt / Equity Ratio	0.71	0.71	0.74	0.88	0.79	0.93
Debt / EBITDA Ratio	1.86	1.95	1.88	1.89	2.29	3.26
Debt / FCF Ratio	-	-	-	-	2.20	16.05
Asset Turnover	-	2.45	2.64	2.98	2.67	2.45
Inventory Turnover	-	7.83	7.49	7.31	6.25	5.14
Quick Ratio	-	0.89	0.89	0.68	0.74	0.71
Current Ratio	-	1.40	1.31	1.28	1.32	1.49
Return on Equity (ROE)	-	23.61%	28.98%	27.22%	19.58%	12.67%
Return on Assets (ROA)	-	7.03%	7.00%	6.73%	5.29%	4.37%
Return on Capital (ROIC)	15.84%	15.10%	16.94%	16.98%	12.17%	8.79%
Return on Capital Employed (ROCE)	-	35.10%	38.20%	40.50%	28.20%	20.20%
Earnings Yield	5.05%	4.46%	4.84%	5.87%	7.94%	7.70%
FCF Yield	-	-1.58%	-3.60%	-9.75%	16.04%	3.75%
Buyback Yield / Dilution	-27.40%	-26.16%	-2.98%	-	0.13%	-40.03%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.